Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Embecta Corp (EMBC)

Embecta Corp (EMBC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,079,027
  • Shares Outstanding, K 57,702
  • Annual Sales, $ 1,121 M
  • Annual Income, $ 70,400 K
  • EBIT $ 166 M
  • EBITDA $ 205 M
  • 60-Month Beta 0.97
  • Price/Sales 0.96
  • Price/Cash Flow 3.79
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 55.06% ( -16.67%)
  • Historical Volatility 88.75%
  • IV Percentile 8%
  • IV Rank 32.33%
  • IV High 129.12% on 03/15/24
  • IV Low 19.67% on 06/03/24
  • Put/Call Vol Ratio 1.31
  • Today's Volume 134
  • Volume Avg (30-Day) 136
  • Put/Call OI Ratio 0.71
  • Today's Open Interest 2,585
  • Open Int (30-Day) 2,352

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 0.40
  • Number of Estimates 3
  • High Estimate 0.59
  • Low Estimate 0.30
  • Prior Year 0.59
  • Growth Rate Est. (year over year) -32.20%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.05 +54.52%
on 11/19/24
20.80 -3.05%
on 11/26/24
+6.27 (+45.07%)
since 10/25/24
3-Month
12.42 +62.36%
on 10/10/24
20.80 -3.05%
on 11/26/24
+5.56 (+38.02%)
since 08/27/24
52-Week
9.93 +103.17%
on 04/15/24
20.80 -3.05%
on 11/26/24
+2.79 (+16.02%)
since 11/27/23

Most Recent Stories

More News
Stocks Slip as Mixed Economic News Warrants a Cautious Fed

The S&P 500 Index ($SPX ) (SPY ) today is down -0.33%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.03%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.12%. Stocks today are mixed, with...

CRWD : 346.97 (-4.76%)
ADSK : 290.28 (-8.71%)
PARA : 10.77 (+1.22%)
$SPX : 5,997.90 (-0.39%)
SYM : 23.20 (-37.98%)
FL : 25.40 (+3.76%)
HPQ : 34.26 (-12.38%)
EMBC : 20.25 (+8.29%)
$IUXX : 20,736.71 (-0.89%)
WDAY : 259.19 (-4.07%)
URBN : 47.97 (+19.51%)
UNH : 608.82 (+0.33%)
Embecta Corp. Declares Quarterly Cash Dividend of $0.15 Per Share

Embecta Corp. declared a quarterly cash dividend of $0.15, payable December 18, 2024, to eligible shareholders.Quiver AI SummaryEmbecta Corp. has announced a quarterly cash dividend of $0.15 per share...

EMBC : 20.25 (+8.29%)
Embecta Corp. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2025 Financial Guidance; Discontinues Insulin Patch Pump Program; and Announces Restructuring to Streamline Operations and Reduce Costs

EMBC : 20.25 (+8.29%)
embecta Announces Quarterly Cash Dividend

EMBC : 20.25 (+8.29%)
UPDATE - embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results

EMBC : 20.25 (+8.29%)
embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results

EMBC : 20.25 (+8.29%)
embecta Celebrates National Diabetes Awareness Month by Ringing Nasdaq Closing Bell

EMBC : 20.25 (+8.29%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Embecta Corp. - EMBC

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Embecta Corp. ("Embecta" or the "Company") (NASDAQ: EMBC). Such investors are...

EMBC : 20.25 (+8.29%)
Campbell Appoints Carrie Anderson Chief Financial Officer

Campbell Soup Company (NYSE:CPB) today announced the appointment of Carrie L. Anderson as Executive Vice President and Chief Financial Officer, effective Feb. 6.

IART : 24.34 (+2.70%)
EMBC : 20.25 (+8.29%)
CPB : 46.19 (-0.88%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Embecta Corp. - EMBC

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Embecta Corp. ("Embecta" or the "Company") (NASDAQ: EMBC). Such investors are...

EMBC : 20.25 (+8.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Embecta Corp. is a pure-play diabetes care company. Embecta is based in FRANKLIN LAKES, N.J.

See More

Key Turning Points

3rd Resistance Point 24.47
2nd Resistance Point 22.63
1st Resistance Point 20.67
Last Price 20.25
1st Support Level 16.87
2nd Support Level 15.03
3rd Support Level 13.07

See More

52-Week High 20.80
Last Price 20.25
Fibonacci 61.8% 16.65
Fibonacci 50% 15.36
Fibonacci 38.2% 14.08
52-Week Low 9.93

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar